— Know what they know.
Not Investment Advice

TOMDF OTC

Todos Medical Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -98.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 50 · $14081 mcap · 1.09B float · 0.0033% daily turnover

Balance Sheet Trends

Total Assets
$15M +1.0% ▲
5Y CAGR: +79.6%
Total Liabilities
$50M +27.5% ▲
5Y CAGR: +87.6%
Shareholders Equity
-$36M -46.7% ▼
Cash & Investments
$34K -82.0% ▼
5Y CAGR: -45.1%
Total Debt
$38M +20.8% ▲
5Y CAGR: +125.4%
Net Debt
$38M +21.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$64K$12K$935K$189K$34K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$64K$12K$935K$189K$34K
Net Receivables$0$0$378K$3M$1M
Inventory$0$0$536K$2M$1M
Other Current Assets$42K$8K$62K$31K$1M
Total Current Assets$106K$26K$2M$5M$3M
Property, Plant & Equip.$93K$65K$2M$2M$1M
Goodwill & Intangibles$0$0$0$8M$14M
Long-Term Investments$0$0$969K$495K$495K
Other Non-Current Assets$0$0$591K$455K$2M
Total Non-Current Assets$93K$65K$4M$10M$12M
Total Assets$199K$91K$6M$15M$15M
— Liabilities —
Accounts Payable$163K$414K$2M$2M$7M
Short-Term Debt$639K$113K$3M$2M$5M
Deferred Revenue$111K$800K$844K$0$0
Other Current Liabilities$273K-$801K$2M$2M$5M
Total Current Liabilities$1M$2M$8M$9M$17M
Long-Term Debt$0$4M$8M$30M$33M
Other Non-Current Liab.$217K$1M$486K$323K$180K
Total Non-Current Liabilities$217K$5M$9M$30M$34M
Total Liabilities$1M$6M$17M$39M$50M
— Equity —
Common Stock$191K$280K$1M$3M$4M
Retained Earnings-$6M-$18M-$47M-$91M-$116M
Accumulated OCI-$83K$0$0$0$0
Total Stockholders Equity-$1M-$6M-$11M-$24M-$36M
Total Liabilities & Equity$199K$91K$6M$15M$15M
— Key Metrics —
Total Debt$630K$4M$11M$32M$38M
Net Debt$566K$4M$11M$32M$38M
Total Investments$0$0$969K$495K$495K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms